References
Alexander SPH, Roberts RE, Broughton BRS, Sobey CG, George CH, Stanford SC, et al. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. Br J Pharmacol 175: 407-411.
Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D’Amico G, et al. (2011). Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7: 89-104.
Beenken A, Eliseenkova AV, Ibrahimi OA, Olsen SK, & Mohammadi M (2012). Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. J Biol Chem 287: 3067-3078.
Beenken A, & Mohammadi M (2009). The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
Bernardim B, Cal PM, Matos MJ, Oliveira BL, Martinez-Saez N, Albuquerque IS, et al. (2016). Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents. Nat Commun 7: 13128.
Brill A, Elinav H, & Varon D (2004). Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 63: 226-235.
Brocchini S, Godwin A, Balan S, Choi JW, Zloh M, & Shaunak S (2008). Disulfide bridge based PEGylation of proteins. Adv Drug Deliv Rev 60: 3-12.
Chu H, Gao J, Chen C, Huard J, & Wang Y (2011). Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci 108: 13444-13449.
Chua CC, Rahimi N, Forsten-Williams K, & Nugent MA (2004). Heparan Sulfate Proteoglycans Function as Receptors for Fibroblast Growth Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2. Circ Res 94: 316-323.
Corseaux D, Meurice T, Six I, Rugeri L, Ezekowitz MD, Rouvier P, et al. (2000). Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. Circulation 101: 2000-2006.
Das A, Huang GX, Bonkowski MS, Longchamp A, Li C, Schultz MB, et al. (2018). Impairment of an Endothelial NAD(+)-H2S Signaling Network Is a Reversible Cause of Vascular Aging. Cell 173: 74-89 e20.
Decker CG, Wang Y, Paluck SJ, Shen L, Loo JA, Levine AJ, et al.(2016). Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing. Biomaterials 81: 157-168.
DeFrees S, Wang ZG, Xing R, Scott AE, Wang J, Zopf D, et al.(2006). GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. Glycobiology 16: 833-843.
Dozier JK, & Distefano MD (2015). Site-Specific PEGylation of Therapeutic Proteins. Int J Mol Sci 16: 25831-25864.
Foley TL, & Burkart MD (2007). Site-specific protein modification: advances and applications. Curr Opin Chem Biol 11: 12-19.
Grinnell F, Ho CH, & Wysocki A (1992). Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416.
Huang Z, Tan Y, Gu J, Liu Y, Song L, Niu J, et al. (2017). Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Rep 20: 1717-1728.
Johnson GL, & Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
Kang CE, Tator CH, & Shoichet MS (2010). Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system. J Control Release 144: 25-31.
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, & Group NCRRGW (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
Krall N, da Cruz FP, Boutureira O, & Bernardes GJ (2016). Site-selective protein-modification chemistry for basic biology and drug development. Nat Chem 8: 103-113.
Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, & Schultz GS (2002). Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10: 26-37.
Li X, Wang C, Xiao J, McKeehan WL, & Wang F (2016). Fibroblast growth factors, old kids on the new block. Semin Cell Dev Biol 53:155-167.
Maddaluno L, Urwyler C, & Werner S (2017). Fibroblast growth factors: key players in regeneration and tissue repair. Development 144:4047-4060.
McGrath JC, & Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
Nguyen TH, Kim SH, Decker CG, Wong DY, Loo JA, & Maynard HD (2013). A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nat Chem 5: 221-227.
Olekson MA, Faulknor R, Bandekar A, Sempkowski M, Hsia HC, & Berthiaume F (2015). SDF-1 liposomes promote sustained cell proliferation in mouse diabetic wounds. Wound Repair Regen 23: 711-723.
Parnaud G, Taché S, Peiffer G, & Corpet DE (1999). Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res 59: 5143-5147.
Potente M, Gerhardt H, & Carmeliet P (2011). Basic and therapeutic aspects of angiogenesis. Cell 146: 873-887.
Rabuka D (2010). Chemoenzymatic methods for site-specific protein modification. Curr Opin Chem Biol 14: 790-796.
Rosen CB, & Francis MB (2017). Targeting the N terminus for site-selective protein modification. Nat Chem Biol 13: 697-705.
Sarabipour S, & Hristova K (2016). Mechanism of FGF receptor dimerization and activation. Nat Commun 7: 10262.
Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, et al. (2000). Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6: 743-750.
Slack JM, Darlington BG, Heath JK, & Godsave SF (1987). Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature 326: 197-200.
Takahashi K, & Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
van Horssen R, Galjart N, Rens JA, Eggermont AM, & ten Hagen TL (2006). Differential effects of matrix and growth factors on endothelial and fibroblast motility: application of a modified cell migration assay. J Cell Biochem 99: 1536-1552.
Xu HL, Chen PP, Wang LF, Tong MQ, Ou ZH, Zhao YZ, et al. (2018). Skin-permeable liposome improved stability and permeability of bFGF against skin of mice with deep second degree scald to promote hair follicle neogenesis through inhibition of scar formation. Colloids Surf B Biointerfaces 172: 573-585.
Zhou J, Cai X, Huang X, Dai Y, Sun L, Zhang B, et al. (2017). A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects. Eur J Med Chem 138: 1158-1169.